- Home
- SIGI vs SRRK Comparison
SIGI vs SRRK Comparison
Compare SIGI & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIGI | SRRK |
|---|---|---|
| Founded | 1926 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.9B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SIGI | SRRK |
|---|---|---|
| Price | $82.63 | $47.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $84.40 | $51.20 |
| AVG Volume (30 Days) | 572.8K | ★ 772.8K |
| Earning Date | 01-01-0001 | 04-10-2026 |
| Dividend Yield | ★ 2.07% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.00 | N/A |
| Revenue Next Year | $4.87 | $21,831.23 |
| P/E Ratio | $11.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $71.75 | $22.71 |
| 52 Week High | $93.38 | $49.82 |
Technical Indicators
Market Signals| Indicator | SIGI | SRRK |
|---|---|---|
| Relative Strength Index (RSI) | 42.71 | 52.82 |
| Support Level | $81.60 | $45.59 |
| Resistance Level | $85.84 | $48.79 |
| Average True Range (ATR) | 2.04 | 1.84 |
| MACD | -0.64 | -0.07 |
| Stochastic Oscillator | 11.56 | 57.92 |
Price Performance
Historical ComparisonAbout SIGI Selective Insurance Group Inc.
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.